| Trial registration number
|
NCT05269017 |
Full text link
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05269017
|
First author
Last imported at : May 13, 2022, 7 a.m.
Source : ClinicalTrials.gov
|
Ahmad Hamdan, MD
|
Contact
Last imported at : May 13, 2022, 7 a.m.
Source : ClinicalTrials.gov
|
Ahmed.Hamdan@med.menofia.edu.eg
|
Registration date
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
2022-03-07
|
Recruitment status
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Not recruiting
|
Study design
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Long covid
|
Inclusion criteria
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
nclusion criteria:
patients should be more than 18 years old,
patients having a history of covid 19 infection more than three months ago as confirmed by pcr test,
patients having a post covid parosmia,
patients having no history of systemic steroid administration over the last one month.
|
Exclusion criteria
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
history of previous nasal surgery,
underlying systemic diseases (like diabetes mellitus, hypertension, or autoimmune diseases),
hypersensitivity to vitamin d3.
|
Number of arms
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Menoufia University
|
Inclusion age min
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Patients recovered from covid
|
Severity scale
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
N/A
|
Total sample size
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
60
|
primary outcome
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Comparison between case and control groups regarding the post treatment results;Comparison between the pre and post treatment values
|
Notes
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
Phase 2
|
Arms
Last imported at : March 8, 2022, 10:30 p.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1371, "treatment_name": "Vitamin d3", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 242, "treatment_name": "Budesonide", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}]
|